The store will not work correctly when cookies are disabled.
Methyl 4-(2,3-dinitroxypropyl)benzoate
ID: ALA2205644
PubChem CID: 71455878
Max Phase: Preclinical
Molecular Formula: C11H12N2O8
Molecular Weight: 300.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: Methyl 4-(2,3-Dinitroxypropyl)Benzoate | CHEMBL2205644|Methyl 4-(2,3-Dinitroxypropyl)Benzoate
Canonical SMILES: COC(=O)c1ccc(CC(CO[N+](=O)[O-])O[N+](=O)[O-])cc1
Standard InChI: InChI=1S/C11H12N2O8/c1-19-11(14)9-4-2-8(3-5-9)6-10(21-13(17)18)7-20-12(15)16/h2-5,10H,6-7H2,1H3
Standard InChI Key: XSIICEOWVNFMCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
14.1325 -48.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8470 -48.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8470 -49.7338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5615 -50.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2760 -49.7338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2760 -48.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5615 -48.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1325 -47.6713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4181 -48.9088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9904 -50.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7049 -49.7338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7049 -48.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4194 -48.4963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4194 -47.6713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1338 -47.2588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7049 -47.2588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4194 -50.1463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1338 -49.7338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1338 -48.9088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8483 -50.1463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7036 -48.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 1 0
14 15 2 0
14 16 1 0
13 14 1 0
12 13 1 0
18 19 2 0
18 20 1 0
17 18 1 0
11 17 1 0
5 10 1 0
9 21 1 0
M CHG 4 14 1 16 -1 18 1 20 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.22 | Molecular Weight (Monoisotopic): 300.0594 | AlogP: 0.80 | #Rotatable Bonds: 8 |
Polar Surface Area: 131.04 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 10 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.26 | CX LogD: 2.26 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.39 | Np Likeness Score: -0.04 |
References
1. Chegaev K, Riganti C, Lazzarato L, Rolando B, Guglielmo S, Campia I, Fruttero R, Bosia A, Gasco A.. (2011) Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity., 2 (7): [PMID:24900337] [10.1021/ml100302t] |